Oximio Expands European Comparator Sourcing Capabilities with Ireland WDA Licence
We are delighted to announce a significant milestone in our global clinical trial support services: the accreditation of a Wholesale Distribution Authorisation (WDA) licence from the Health Products Regulatory Authority (HPRA) in Ireland. This development marks a key expansion of our procurement and comparator sourcing capabilities across Europe, enabling us to offer enhanced support to clinical trial sponsors, CROs, CDMOs and Academia throughout the region.
With over 20 years of industry experience, our team continues to build on a strong foundation of regulatory compliance, operational excellence, and global reach. The newly secured WDA licence complements our existing WDA accreditation from the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK, reinforcing our position as a trusted supply chain solutions partner for the healthcare industry.
Expanded Services to Meet European Procurement Needs
Our European comparator sourcing services for clinical trials now include:
- Tailored Comparator Drug Sourcing
Customised solutions to source high-quality, often hard-to-find comparator drugs with competitive pricing and efficient lead times. - Robust Supplier Network & Regulatory Assurance
Procurement through our network of approved suppliers ensures adherence to EU regulations and streamlined sourcing processes. - Expedited Processing Across Borders
With minimal “PO to Dispatch” timelines, we support urgent and multi-country study requirements. - Comprehensive Documentation
Full documentation including CoA, CoC, and MSDS is available, where stated, for most products within our portfolio.
A Collaborative Approach to Global Clinical Trials
At the heart of our service is a client-focused, collaborative approach. We work closely with trial sponsors and procurement teams to align comparator sourcing strategies with the specific needs of each study. Whether it’s negotiating bulk orders, navigating regulatory complexities, or managing supply chain logistics, our goal is to simplify procurement while maintaining the highest standards of quality and reliability.
This latest milestone supports our continued EU growth plans and reaffirms our mission to help bring innovative treatments to patients across Europe.
Contact us today to find out how our European sourcing capabilities can support your upcoming clinical trials. We’d be delighted to discuss your requirements.
